Zantac

July 18, 2025

Zantac Lawsuit Update

Our attorneys also provide the latest updates from the Zantac class action lawsuit (including the disastrous news of the class action judge dismissing all of the federal court Zantac lawsuits. This page was updated on August 13, 2025.

Zantac Cancer Lawsuit Updates 2025

The Zantac litigation has been a rollercoaster, filled with major victories, setbacks, and unexpected twists. From the initial discovery of NDMA contamination to the collapse of certain cases and the resurgence of others, this litigation has had a lot of turns.

July 3, 2024

Zantac Bladder Cancer Lawsuit

by Ronald V. Miller, Jr.

Bladder cancer is the focus of the ongoing Zantac lawsuit. In this post, we will look at bladder cancer in personal injury lawsuits.

As of 2025, bladder cancer has emerged as the strongest claim in the Zantac litigation. Among the various cancers originally alleged, the scientific evidence linking Zantac (ranitidine) to bladder cancer is particularly compelling. This is due to the way NDMA forms after ingestion and accumulates in the bladder. By contrast, recent trials involving Zantac-related prostate cancer have not gone well for plaintiffs, which has only reinforced the shift toward focusing on stronger claims.

Our firm is now accepting new Zantac lawsuits only for individuals diagnosed with bladder or liver cancer. If you developed bladder cancer after using Zantac regularly, you may be eligible to file a claim in state court.

May 30, 2024

Zantac Cancer Lawsuit

by Ronald V. Miller, Jr.

The Zantac litigation continues to move forward in state court. The Zantac state court litigation will have a slightly more narrowed focus compared to the initial class action MDL in federal court. The Zantac litigation will focus more on specific types of cancer that have the strongest evidence linking them to NDMA and Zantac use.

What is the expected individual settlement payout in the Zantac lawsuit

What kind of cancer does NDMA cause?